AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

G-Zidd 60M SR Tablet

Prescription Icon
Prescription Required

Marketer

SAG Health Science Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview G-Zidd 60M SR Tablet

Diabeva 60MG Extended-Release tablets are antidiabetic medications combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Diabeva 60MG Extended-Release tablets should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. To mitigate hypoglycemia, maintain regular mealtimes and carry a readily available fast-acting glucose source. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function as advised by your doctor.

Uses of G-Zidd 60M SR Tablet

Non-insulin-dependent diabetes

Major Benefits of G-Zidd 60M SR Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the G-Zidd 60M SR Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of G-Zidd 60M SR Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use G-Zidd 60M SR Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The G-Zidd 60M SR Tablet should be administered with a meal.

How G-Zidd 60M SR Tablet works:

Gliclazide and metformin are combined in the extended-release G-Zidd 60M SR tablet to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining G-Zidd 60M SR Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using G-Zidd 60M SR Tablets during pregnancy poses a confirmed risk to fetal development, making it inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of G-Zidd 60M SR Tablet while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use G-Zidd 60M SR Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use G-Zidd 60M SR Tablet cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, initiation at a low dose is typical; however, it's contraindicated in severe cases.

What if you forget to take G-Zidd 60M SR Tablet :

Should you forget a G-Zidd 60M SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About G-Zidd 60M SR Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on G-Zidd 60M SR Tablet

G-Zidd 60M SR Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
G-Zidd 60M SR Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
G-Zidd 60M SR Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
G-Zidd 60M SR Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience any of these, discontinue G-Zidd 60M SR Tablets and seek immediate medical attention.
Prolonged use of G-Zidd 60M SR Tablet can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
G-Zidd 60M SR Tablet is contraindicated in patients with hypersensitivity to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with G-Zidd 60M SR Tablet is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
G-Zidd 60M SR Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
G-Zidd 60M SR Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
G-Zidd 60M SR Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
G-Zidd 60M SR Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue G-Zidd 60M SR Tablets and seek immediate medical attention.
Prolonged G-Zidd 60M SR Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues), cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
G-Zidd 60M SR Tablet is contraindicated in patients allergic to its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with G-Zidd 60M SR Tablet is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
G-Zidd 60M SR Tablet
43
MRP 52
17% off